Published 17:39 IST, February 23rd 2024
Biocon faces GST penalty worth over Rs 3 crore
The penalty pertains to errors in input tax credit reporting in GST monthly returns, denial of input tax credit on sales, and promotional expenses.
![Biocon Biologics Receives MHRA Approval for Biosimilar, Yesafili](https://img.republicworld.com/tr:w-800,h-450,q-75,f-auto/rimages/2-0-283929040-biocon-0_1680508382348_1682445052820-169988012830916_9.webp)
Biocon faces GST penalty worth over Rs 3 crore
| Image:
Biocon Biologics
- Listen to this article
- 1 min read
Advertisement
17:39 IST, February 23rd 2024